Public Relations  >  News Center  >  School of Medicine
School of Medicine: Indicators of Excellence

In 2013, 6,955 prospective students applied to the Creighton University School of Medicine for 152 first-year seats.

Creighton matched 94 percent of its 2013 graduating medical students with their specialties of choice.

Creighton medical graduates are offered residency training at excellent medical centers from coast to coast. Students were matched with residencies in 33 states and the District of Columbia at programs such as Mayo School of Graduate Medical Education and Mayo Clinic, UCLA, Dartmouth, Emory, Georgetown, Vanderbilt, University of North Carolina, Weill-Cornell, Yale, Creighton, St. Joseph?s Hospital and Medical Center in Phoenix, Duke, Yale and Northwestern. They select Creighton medical school graduates for reasons that include Creighton?s comprehensive clinical training, rigorous academics, excellent student performance, outstanding student support and mentoring systems, and the University?s national reputation for excellence.

Creighton consistently ranks above the national average in graduate satisfaction. In a recent survey, nearly 95 percent of 2012 graduates said they were pleased with the quality of their medical education.

Creighton faculty pride themselves on being teachers first and foremost. The accrediting authority for U.S. and Canadian doctor of medicine programs has described Creighton faculty as ?enthusiastic about teaching ?The extraordinary availability of the faculty and administrative staff strongly supports the learning environment.?

The School of Medicine promotes service among its students and 100 percent voluntarily participate in community service activities. Creighton University was the first Catholic higher education institution to receive the prestigious Community Service Award from the Association of American Medical Colleges for its work in the Magis Clinic. This free clinic, founded and run by Creighton medical students with the assistance of physician volunteers, provides healthcare for the uninsured and underinsured.

Creighton University School of Medicine was named a national Center of Excellence for Physician Information for the National Institute on Drug Abuse in 2007. These centers serve as national models for educating future physicians about drug abuse and addiction so they can better identify, prevent and treat patients at risk.

The School of Medicine was selected in 2006 to participate in an Innovative Strategies for Transforming the Education of Physicians (ISTEP) project sponsored by the American Medical Association (AMA). ISTEP is a unique medical education research collaborative that brings together individuals and institutions from across the continuum of physician learning. Creighton is one of 16 research teams that represent 27 medical schools participating in the AMA research.

Creighton has a long and rich history of groundbreaking research that makes a difference in people?s lives by discovering the underlying causes of disease as well as new ways to prevent and treat disease. Research awards to Creighton University for the 2012-13 academic year totaled $28.8 million.

  • The high caliber of ongoing research by the faculty at Creighton University has been validated through several forms of national peer review; much of the current research is funded by the NIH or other national granting agencies. More than 30 active NIH grants fund studies at Creighton ranging from the basic sciences, including the work of Tim and Kristina Simeone, Ph.D., to better understand the mysteries of epilepsy and the research of Anthony Kincaid, Ph.D., P.T., which studies how infectious proteins enter the nervous system, to true translational research such as that undertaken by Martha Nunn, D.D.S., Ph.D., who is seeking to establish a global standard for tooth extraction indicators.
  • Creighton is also home to world-renowned researchers in bone biology, hereditary cancer and asthma and allergies. Trailblazers like Robert Heaney, M.D., and Henry Lynch, M.D., have spent decades in Creighton?s labs developing findings that now drive policy and treatment protocol throughout the world.


Creighton University School of Medicine and St. Joseph's Hospital and Medical Center in Phoenix, Ariz., announced an academic affiliation in June 2009 that creates a Creighton medical school presence in Phoenix. The affiliation expands educational opportunities available to Creighton medical students while allowing the School of Medicine to recruit more students and gives them access to a Catholic-based medical education. Students are exposed to additional complementary areas of clinical excellence and collaborative research opportunities.

On September 1, 2012, Alegent Health and Creighton University expanded their strategic academic affiliation to form Alegent Creighton Health and Alegent Creighton Clinic. Alegent Creighton Health is one of the top 15 healthcare systems in the U. S. and provides the primary teaching sites for the School of Medicine and Creighton?s other health sciences schools. Creighton University is responsible for the education component of the affiliation, enhancing both the academic experience for students and healthcare in the greater Omaha community.
Centers of Excellence:

  • The Osteoporosis Research Center has been recognized for decades as one of the top bone research and clinical treatment centers in the world. The center has played a pivotal role in the identification of osteoporosis as a serious health threat, particularly to postmenopausal women, and in the development of current standards for osteoporosis screening, diagnosis, treatment and prevention.
  • The Cardiac Center of Creighton University is the only free-standing facility of its kind in Omaha dedicated solely to cardiovascular care, teaching and research.
  • The Center for Research in Anti-Infectives and Biotechnology looks at the many aspects of antimicrobial chemotherapy, ranging from drug discovery to the molecular mechanisms of antibacterial resistance among bacteria, antibacterial resistance in the clinical laboratory, and new drugs and drug combinations to treat resistant bacteria.
  • The Hereditary Cancer Center is devoted to cancer prevention resulting from hereditary cancer syndromes, with particular attention given to surveillance and management programs melded to the natural history of these particular disorders.